LIVER TRANSIENT ELASTOMETRY FOR EVALUATING LIVER FIBROSIS IN PATIENTS WITH HEPATITIS C AND HIV-COINFECTION RECEIVING ANTIVIRAL THERAPY
HIV infection and chronic hepatitis C (CHC) is a global public health problem. During the last two decades, many researchers have attempted to develop effective treatment. Interferon-based therapy helped a lot of patients. Over the last decade, considerable advances have been made in the treatment of hepatitis C in HIV-coinfected patients. In addition to biochemical and virological parameters, the dynamics of fibrotic changes in liver assessed by transient elastometry (TE) can also be used for estimating treatment efficacy. TE can be used for monitoring the efficacy of antiviral therapy in patients with HIV/CHC.